Pages that link to "Q30432271"
Jump to navigation
Jump to search
The following pages link to Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues (Q30432271):
Displaying 42 items.
- Possible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseases (Q27024349) (← links)
- A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms (Q27336229) (← links)
- Structural Mechanism of the Interaction of Alzheimer Disease Aβ Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide (Q30379691) (← links)
- Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies (Q33893017) (← links)
- 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease (Q34370099) (← links)
- Identification of aggregation inhibitors of the human antibody light chain repertoire by phage display (Q35211434) (← links)
- Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation (Q36056679) (← links)
- Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy (Q36335013) (← links)
- Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease (Q38240609) (← links)
- Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability (Q38374202) (← links)
- Alzheimer's Disease, Drosophila melanogaster and Polyphenols. (Q38532705) (← links)
- Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery. (Q38534395) (← links)
- Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design (Q38558352) (← links)
- Role of norepinephrine in Aβ-related neurotoxicity: dual interactions with Tyr10 and SNK(26-28) of Aβ. (Q38722235) (← links)
- Natural product-based amyloid inhibitors. (Q38733078) (← links)
- Aβ-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and Aβ Secretion in Neural Cells (Q38769556) (← links)
- Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease. (Q38841062) (← links)
- Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42. (Q42872785) (← links)
- Inhibition of HEWL fibril formation by taxifolin: Mechanism of action. (Q46262746) (← links)
- Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer's Disease. (Q47848417) (← links)
- Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2/prostaglandin E2 content. (Q52654784) (← links)
- Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity. (Q53193984) (← links)
- Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways. (Q53355168) (← links)
- Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms (Q57159243) (← links)
- Effects of hydroxyl group variations on a flavonoid backbone toward modulation of metal-free and metal-induced amyloid-β aggregation (Q57975781) (← links)
- Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease (Q58573301) (← links)
- Synthesis and effects of flavonoid structure variation on amyloid-β aggregation (Q58896414) (← links)
- Methanolic extract of attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats (Q60054889) (← links)
- A cationic polymethacrylate-copolymer acts as an agonist for β-amyloid and an antagonist for amylin fibrillation (Q62556750) (← links)
- Preparation and characterization of general-purpose gelatin-based co-loading flavonoids nano-core structure (Q64095645) (← links)
- Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion. (Q64957468) (← links)
- Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives. (Q64991552) (← links)
- Evaluation of Toxic Amyloid 42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator (Q89697243) (← links)
- Mechanistic approaches for chemically modifying the coordination sphere of copper-amyloid-β complexes (Q89899597) (← links)
- An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease (Q90007223) (← links)
- Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease (Q90399703) (← links)
- Phytochemical profile of Paulownia tomentosa (Thunb). Steud (Q90669898) (← links)
- Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy (Q91622738) (← links)
- Neuroprotective Effects of Quercetin in Alzheimer's Disease (Q92443490) (← links)
- 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo (Q92572699) (← links)
- Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties (Q92723849) (← links)
- Simulations on the dual effects of flavonoids as suppressors of Aβ42 fibrillogenesis and destabilizers of mature fibrils (Q100464393) (← links)